Financhill
Back

Summit Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.

Summit Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 20.01 Buy
20-day SMA: 22.89 Sell
50-day SMA: 23.35 Sell
200-day SMA: 20.5 Buy
8-day EMA: 21.35 Buy
20-day EMA: 22.42 Sell
50-day EMA: 22.78 Sell
200-day EMA: 19.28 Buy

Summit Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.94 Sell
Relative Strength Index (14 RSI): 48.06 Sell
Chaikin Money Flow: -1784690 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Summit Therapeutics Stock

Is Summit Therapeutics Stock a Buy?

SMMT Technical Analysis vs Fundamental Analysis

Sell
44
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy or a Sell?

Summit Therapeutics Stock Info

Market Cap:
16.4B
Price in USD:
22.08
Share Volume:
3.5M

Summit Therapeutics 52-Week Range

52-Week High:
36.91
52-Week Low:
6.78
Sell
44
Summit Therapeutics (SMMT) is a Sell

Summit Therapeutics Share Price Forecast

Is Summit Therapeutics Stock a Buy?

  • Summit Therapeutics share price is 22.08 while SMMT 8-day exponential moving average is 21.35, which is a Buy signal.
  • The stock price of SMMT is 22.08 while Summit Therapeutics 20-day EMA is 22.42, which makes it a Sell.
  • Summit Therapeutics 50-day exponential moving average is 22.78 while SMMT share price is 22.08, making it a Sell technically.
  • SMMT stock price is 22.08 and Summit Therapeutics 200-day simple moving average is 19.28, creating a Buy signal.

Fundamental Analysis of Summit Therapeutics

Is Summit Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.

Technical Analysis of Summit Therapeutics

Should I short Summit Therapeutics stock?

* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.